|
1AUD
U1A-UTRRNA, NMR, 31 STRUCTURES
Deposited 1997-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
2–102(101 aa)
Fragment:RESIDUES 1 - 102 OF U1A
|
Mutation:Y30H, Q35R
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
Ionic strength (raw mmCIF value) 50 mM NACL
|
Resolution not provided
|
|
1DRZ
U1A SPLICEOSOMAL PROTEIN/HEPATITIS DELTA VIRUS GENOMIC RIBOZYME COMPLEX
Deposited 1998-09-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
2–98(97 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 3
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.0
|
Resolution 2.30 Å
R-free 0.284
|
|
1DZ5
The NMR structure of the 38KDa U1A protein-PIE RNA complex reveals the basis of cooperativity in regulation of polyadenylation by human U1A protein
Deposited 2000-02-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
2–102(101 aa)
Fragment:RESIDUES 2-102
Chain B
2–102(101 aa)
Fragment:RESIDUES 2-102
|
Mutation:YES
Mutation:YES
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;300 K;Ionic strength (raw mmCIF value) 10MM PHOSPHATE BUFFER;Pressure 1
NMR sample composition
10MM PHOSPHATE BUFFER
|
Resolution not provided
|
|
1FHT
RNA-BINDING DOMAIN OF THE U1A SPLICEOSOMAL PROTEIN U1A117, NMR, 43 STRUCTURES
Deposited 1996-02-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–117(116 aa)
Fragment:N-TERMINAL DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1M5K
Crystal structure of a hairpin ribozyme in the catalytically-active conformation
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain F
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 16
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, ammonium chloride, calcium chloride, pH 5.0, VAPOR DIFFUSION,
SITTING DROP at 300K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å
R-free 0.284
|
|
1M5K
Crystal structure of a hairpin ribozyme in the catalytically-active conformation
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 17
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, ammonium chloride, calcium chloride, pH 5.0, VAPOR DIFFUSION,
SITTING DROP at 300K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å
R-free 0.284
|
|
1M5O
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 20
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, calcium Chloride, ammonium chloride, meta-ammonium vanadate,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.20 Å
R-free 0.264
|
|
1M5O
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain F
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 17
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, calcium Chloride, ammonium chloride, meta-ammonium vanadate,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.20 Å
R-free 0.264
|
|
1M5P
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain C
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, calcium Chloride, ammonium chloride, meta-ammonium vanadate,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.60 Å
R-free 0.280
|
|
1M5P
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain F
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, calcium Chloride, ammonium chloride, meta-ammonium vanadate,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.60 Å
R-free 0.280
|
|
1M5V
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain C
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 13
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, ammonium chloride, calcium chloride,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.40 Å
R-free 0.265
|
|
1M5V
Transition State Stabilization by a Catalytic RNA
Deposited 2002-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain F
1–100(100 aa)
Fragment:U1A RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 21
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;300 K;MPD, ammonium chloride, calcium chloride,
pH 5.0, VAPOR DIFFUSION, SITTING DROP at 300K
|
Resolution 2.40 Å
R-free 0.265
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 2
MLA MALONIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 3
MLA MALONIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
2–98(97 aa)
Fragment:U1A RBD1
Chain B
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 15
MLA MALONIC ACID × 36
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 9
MLA MALONIC ACID × 18
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 6
MLA MALONIC ACID × 18
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 4
MLA MALONIC ACID × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1NU4
U1A RNA binding domain at 1.8 angstrom resolution reveals a pre-organized C-terminal helix
Deposited 2003-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–98(97 aa)
Fragment:U1A RBD1
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 6
MLA MALONIC ACID × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;Potassium Malonate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.234
|
|
1OIA
U1A rnp domain 1-95
Deposited 2003-06-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–95(95 aa)
Fragment:RNP DOMAIN RESIDUES 1-95
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.5;2M NA/K PHOSPHATE PH 5.5
|
Resolution 2.40 Å
R-free 0.242
|
|
1OIA
U1A rnp domain 1-95
Deposited 2003-06-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–95(95 aa)
Fragment:RNP DOMAIN RESIDUES 1-95
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.5;2M NA/K PHOSPHATE PH 5.5
|
Resolution 2.40 Å
R-free 0.242
|
|
1SJ3
Hepatitis Delta Virus Gemonic Ribozyme Precursor, with Mg2+ Bound
Deposited 2004-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–100(100 aa)
Fragment:RNA binding domain
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;NaCl, MgCl2, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.282
|
|
1SJ4
Crystal structure of a C75U mutant Hepatitis Delta Virus ribozyme precursor, in Cu2+ solution
Deposited 2004-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–100(100 aa)
Fragment:RNA binding domain
|
Mutation:Y31H, Q36R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;NaCl, CuSO4, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.70 Å
R-free 0.282
|
|
1SJF
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Precursor, with C75U mutaion, in Cobalt Hexammine solution
Deposited 2004-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
NCO COBALT HEXAMMINE(III) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;Cobalt Herxammine, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.75 Å
R-free 0.275
|
|
1U6B
CRYSTAL STRUCTURE OF A SELF-SPLICING GROUP I INTRON WITH BOTH EXONS
Deposited 2004-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
1–98(98 aa)
|
Mutation:Y31H,Q36R
|
K POTASSIUM ION × 5
MG MAGNESIUM ION × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.80
|
Resolution 3.10 Å
R-free 0.279
|
|
1URN
U1A MUTANT/RNA COMPLEX + GLYCEROL
Deposited 1995-01-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
2–98(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
CRYSTALLIZATION CONDITIONS: 1.8M (NH4)2 SO4, 40MM TRIS-HCL
PH 7.0, 5MM SPERMINE TRANSFERRED TO 1.9M (NH4)2 SO4, 40MM
TRIS-HCL PH 7.0, 5MM SPERMINE, 25% GLYCEROL FOR 15 MINUTES
BEFORE FREEZING.
|
Resolution 1.92 Å
|
|
1URN
U1A MUTANT/RNA COMPLEX + GLYCEROL
Deposited 1995-01-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
2–98(97 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
CRYSTALLIZATION CONDITIONS: 1.8M (NH4)2 SO4, 40MM TRIS-HCL
PH 7.0, 5MM SPERMINE TRANSFERRED TO 1.9M (NH4)2 SO4, 40MM
TRIS-HCL PH 7.0, 5MM SPERMINE, 25% GLYCEROL FOR 15 MINUTES
BEFORE FREEZING.
|
Resolution 1.92 Å
|
|
1URN
U1A MUTANT/RNA COMPLEX + GLYCEROL
Deposited 1995-01-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
2–98(97 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
CRYSTALLIZATION CONDITIONS: 1.8M (NH4)2 SO4, 40MM TRIS-HCL
PH 7.0, 5MM SPERMINE TRANSFERRED TO 1.9M (NH4)2 SO4, 40MM
TRIS-HCL PH 7.0, 5MM SPERMINE, 25% GLYCEROL FOR 15 MINUTES
BEFORE FREEZING.
|
Resolution 1.92 Å
|
|
1VBX
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Precursor, with C75U mutaion, in EDTA solution
Deposited 2004-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;NaCl, EDTA, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.70 Å
R-free 0.285
|
|
1VBY
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Precursor, with C75U mutaion, and Mn2+ bound
Deposited 2004-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
MN MANGANESE (II) ION × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;MnCl2, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.90 Å
R-free 0.284
|
|
1VBZ
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Precursor, with C75U mutaion, in Ba2+ solution
Deposited 2004-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
BA BARIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;BaCl2, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.268
|
|
1VC0
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Precursor, with C75U mutaion, in Imidazole and Sr2+ solution
Deposited 2004-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
SR STRONTIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;SrCl2, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.50 Å
R-free 0.273
|
|
1VC5
Crystal Structure of the Wild Type Hepatitis Delta Virus Gemonic Ribozyme Precursor, in EDTA solution
Deposited 2004-03-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;EDTA, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.40 Å
R-free 0.327
|
|
1VC6
Crystal Structure of the Hepatitis Delta Virus Gemonic Ribozyme Product with C75U Mutaion, cleaved in Imidazole and Mg2+ solutions
Deposited 2004-03-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD(residues 1-100)
|
Mutation:Y31H/Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;Imidazole, Mg2+, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.284
|
|
1ZZN
Crystal structure of a group I intron/two exon complex that includes all catalytic metal ion ligands.
Deposited 2005-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
1–97(97 aa)
Fragment:RRM 1
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 5
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;298 K;MPD, sodium cacodylate, magnesium acetate, potassium chloride, cobalt heximine, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.37 Å
R-free 0.307
|
|
2A3J
Structure of URNdesign, a complete computational redesign of human U1A protein
Deposited 2005-06-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–80(78 aa)
Fragment:RNA binding domain, residues 2-97
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 50 mM sodium phosphate;Pressure ambient
NMR sample composition
U-15N,variant of U1A, 50 mM Sodium Phosphate,5% D2O | 5% D2O in water
NMR sample composition
U-15N, 13C, variant of U1A, 50 mM Sodium Phosphate, 5% D2O | 5% D2O in water
|
Resolution not provided
|
|
2NZ4
Structural investigation of the GlmS ribozyme bound to its catalytic cofactor
Deposited 2006-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
4–97(94 aa)
Fragment:RNA Binding Domain
|
Mutation:Y31H, Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M sodium cacodylate pH 6.8, 0.02M magnesium chloride, 0.15M potassium chloride, 0.002M glucosamine 6 phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.269
|
|
2NZ4
Structural investigation of the GlmS ribozyme bound to its catalytic cofactor
Deposited 2006-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
4–97(94 aa)
Fragment:RNA Binding Domain
|
Mutation:Y31H, Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M sodium cacodylate pH 6.8, 0.02M magnesium chloride, 0.15M potassium chloride, 0.002M glucosamine 6 phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.269
|
|
2NZ4
Structural investigation of the GlmS ribozyme bound to its catalytic cofactor
Deposited 2006-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
4–97(94 aa)
Fragment:RNA Binding Domain
|
Mutation:Y31H, Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M sodium cacodylate pH 6.8, 0.02M magnesium chloride, 0.15M potassium chloride, 0.002M glucosamine 6 phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.269
|
|
2NZ4
Structural investigation of the GlmS ribozyme bound to its catalytic cofactor
Deposited 2006-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
4–97(94 aa)
Fragment:RNA Binding Domain
|
Mutation:Y31H, Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M sodium cacodylate pH 6.8, 0.02M magnesium chloride, 0.15M potassium chloride, 0.002M glucosamine 6 phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.269
|
|
2OIH
Hepatitis Delta Virus gemonic ribozyme precursor with C75U mutation and bound to monovalent cation Tl+
Deposited 2007-01-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–99(99 aa)
|
Not recorded
|
TL THALLIUM (I) ION × 15
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;containing 5-10% (v/v) MPD, 50 mM sodium cacodylate, pH 6.0, 40-80 mM NaCl, 30 mM SrCl2, and 15-50 mM spermine HCl, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å
R-free 0.288
|
|
2OJ3
Hepatitis Delta Virus ribozyme precursor structure, with C75U mutation, bound to Tl+ and cobalt hexammine (Co(NH3)63+)
Deposited 2007-01-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–99(99 aa)
|
Not recorded
|
NCO COBALT HEXAMMINE(III) × 2
TL THALLIUM (I) ION × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;5-10% (v/v) MPD, 50 mM sodium cacodylate, pH 6.0, 40-80 mM NaCl, 30 mM SrCl2, and 15-50 mM spermine HCl, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.90 Å
R-free 0.263
|
|
2U1A
RNA BINDING DOMAIN 2 OF HUMAN U1A PROTEIN, NMR, 20 STRUCTURES
Deposited 1997-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
195–282(88 aa)
Fragment:RNA BINDING DOMAIN 2, RBD2
|
Mutation:P2A
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K
|
Resolution not provided
|
|
3BO2
A relaxed active site following exon ligation by a group I intron
Deposited 2007-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: pentameric
|
Chain A
4–98(95 aa)
Fragment:RRM 1 domain
|
Not recorded
|
MG MAGNESIUM ION × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;298 K;MPD, Sodium Cacodylate, Magnesium Acetate, Potassium Acetate, Cobalt Hexamine, Potassium Vanadate, pH 6.80, vapor diffusion, hanging drop, temperature 298K
|
Resolution 3.31 Å
R-free 0.321
|
|
3BO3
A relaxed active site following exon ligation by a group I intron
Deposited 2007-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
4–98(95 aa)
Fragment:RRM 1 domain
|
Not recorded
|
MG MAGNESIUM ION × 13
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;298 K;MPD, Sodium Cacodylate, Magnesium Acetate, Potassium Acetate, Cobalt Hexamine, pH 6.80, vapor diffusion, hanging drop, temperature 298K
|
Resolution 3.40 Å
R-free 0.325
|
|
3BO4
A relaxed active site following exon ligation by a group I intron
Deposited 2007-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
4–98(95 aa)
Fragment:RRM 1 domain
|
Not recorded
|
MG MAGNESIUM ION × 12
K POTASSIUM ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;298 K;MPD, Sodium Cacodylate, Magnesium Acetate, Potassium Acetate, Cobalt Hexamine, Potassium Vanadate, pH 6.80, vapor diffusion, hanging drop, temperature 298K
|
Resolution 3.33 Å
R-free 0.296
|
|
3CUL
Aminoacyl-tRNA synthetase ribozyme
Deposited 2008-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 8
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;295 K;100 mM magnesium formate, 15% PEG 3000, 1 M lithium chloride, pH 7.0, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.80 Å
R-free 0.283
|
|
3CUL
Aminoacyl-tRNA synthetase ribozyme
Deposited 2008-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;295 K;100 mM magnesium formate, 15% PEG 3000, 1 M lithium chloride, pH 7.0, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.80 Å
R-free 0.283
|
|
3CUN
Aminoacyl-tRNA synthetase ribozyme
Deposited 2008-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 5
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;295 K;100 mM magenesium formate pH 7.0, 15% PEG 3000, 1 M lithium chloride, VAPOR DIFFUSION, temperature 295K
|
Resolution 3.00 Å
R-free 0.303
|
|
3CUN
Aminoacyl-tRNA synthetase ribozyme
Deposited 2008-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 4
CO COBALT (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;295 K;100 mM magenesium formate pH 7.0, 15% PEG 3000, 1 M lithium chloride, VAPOR DIFFUSION, temperature 295K
|
Resolution 3.00 Å
R-free 0.303
|
|
3EGZ
Crystal structure of an in vitro evolved tetracycline aptamer and artificial riboswitch
Deposited 2008-09-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 4
PDB declaration: octameric
|
Chain A
1–98(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 48
CTC 7-CHLOROTETRACYCLINE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;296 K;0.3 mM RNA, 0.33 mM selenomethionine labeled U1A-RBD double mutant, 0.5 mM chlorotetracycline, 50 mM Tris pH 7.5, 5 mM MgCl2, 0.25 mM spermine; 1uL macromolecular complex:1 uL reservoir; 50 mM HEPES-KOH pH 7.0, 20 mM MGCl2, 12.5-15% PEG 8000; cryo 30% glycerol, 50 mM HEPES-KOH pH 7.0, 20 mM MGCl2, 15% PEG 8000, 0.5 mM spermine, 0.5 mM chlorotetracycline, VAPOR DIFFUSION, SITTING DROP, temperature 296K
|
Resolution 2.20 Å
R-free 0.260
|
|
3G8S
Crystal structure of the pre-cleaved Bacillus anthracis glmS ribozyme
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 3.10 Å
R-free 0.306
|
|
3G8S
Crystal structure of the pre-cleaved Bacillus anthracis glmS ribozyme
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 3.10 Å
R-free 0.306
|
|
3G8S
Crystal structure of the pre-cleaved Bacillus anthracis glmS ribozyme
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 3.10 Å
R-free 0.306
|
|
3G8S
Crystal structure of the pre-cleaved Bacillus anthracis glmS ribozyme
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 3.10 Å
R-free 0.306
|
|
3G8T
Crystal structure of the G33A mutant Bacillus anthracis glmS ribozyme bound to GlcN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.00 Å
R-free 0.318
|
|
3G8T
Crystal structure of the G33A mutant Bacillus anthracis glmS ribozyme bound to GlcN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.00 Å
R-free 0.318
|
|
3G8T
Crystal structure of the G33A mutant Bacillus anthracis glmS ribozyme bound to GlcN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.00 Å
R-free 0.318
|
|
3G8T
Crystal structure of the G33A mutant Bacillus anthracis glmS ribozyme bound to GlcN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.00 Å
R-free 0.318
|
|
3G96
Crystal structure of the Bacillus anthracis glmS ribozyme bound to MaN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.01 Å
R-free 0.311
|
|
3G96
Crystal structure of the Bacillus anthracis glmS ribozyme bound to MaN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
6MN 2-amino-2-deoxy-6-O-phosphono-alpha-D-mannopyranose × 1
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.01 Å
R-free 0.311
|
|
3G96
Crystal structure of the Bacillus anthracis glmS ribozyme bound to MaN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.01 Å
R-free 0.311
|
|
3G96
Crystal structure of the Bacillus anthracis glmS ribozyme bound to MaN6P
Deposited 2009-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP residues 1 to 98)
|
Mutation:Y31H,Q36R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 3.01 Å
R-free 0.311
|
|
3G9C
Crystal structure of the product Bacillus anthracis glmS ribozyme
Deposited 2009-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
GLP 2-amino-2-deoxy-6-O-phosphono-alpha-D-glucopyranose × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.90 Å
R-free 0.307
|
|
3G9C
Crystal structure of the product Bacillus anthracis glmS ribozyme
Deposited 2009-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.90 Å
R-free 0.307
|
|
3G9C
Crystal structure of the product Bacillus anthracis glmS ribozyme
Deposited 2009-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.90 Å
R-free 0.307
|
|
3G9C
Crystal structure of the product Bacillus anthracis glmS ribozyme
Deposited 2009-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.90 Å
R-free 0.307
|
|
3HHN
Crystal structure of class I ligase ribozyme self-ligation product, in complex with U1A RBD
Deposited 2009-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain B
2–98(97 aa)
Fragment:RNA binding domain: UNP residues 1-100
Chain D
2–98(97 aa)
Fragment:RNA binding domain: UNP residues 1-100
|
Mutation:Y31H, Q31R
Mutation:Y31H, Q31R
|
MG MAGNESIUM ION × 34
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;50mM Sodium cacodylate pH 6.0, 40mM Magnesium acetate, 26% 2-methyl-2,4-pentane diol (MPD), 1mM Spermine HCl. Diffraction-quality crystals grown by microseeding., VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.99 Å
R-free 0.234
|
|
3IIN
Plasticity of the kink turn structural motif
Deposited 2009-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: tetrameric
|
Chain A
4–98(95 aa)
Fragment:UNP residues 4-98, RRM 1, U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A RNA BINDING DOMAIN
|
Mutation:Y31H, Q36R
|
K POTASSIUM ION × 5
MG MAGNESIUM ION × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;298 K;MPD, Sodium Cacodylate, Magnesium Acetate, Potassium Acetate, Cobalt Hexamine, pH 6.8, vapor diffusion, hanging drop, temperature 298K
|
Resolution 4.18 Å
R-free 0.323
|
|
3IRW
Structure of a c-di-GMP riboswitch from V. cholerae
Deposited 2009-08-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:RNA Binding Domain
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
IRI IRIDIUM HEXAMMINE ION × 9
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;298 K;22% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å
R-free 0.251
|
|
3IWN
Co-crystal structure of a bacterial c-di-GMP riboswitch
Deposited 2009-09-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
6–96(91 aa)
Fragment:UNP residues 6-96, RRM 1 domain
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;303 K;30% PEG3350
0.1M Tris pH8.5
0.3M ammonium acetate pH7.0
3mM MgCl2
1 mM spermine
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 303K
|
Resolution 3.20 Å
R-free 0.292
|
|
3IWN
Co-crystal structure of a bacterial c-di-GMP riboswitch
Deposited 2009-09-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain D
6–96(91 aa)
Fragment:UNP residues 6-96, RRM 1 domain
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;303 K;30% PEG3350
0.1M Tris pH8.5
0.3M ammonium acetate pH7.0
3mM MgCl2
1 mM spermine
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 303K
|
Resolution 3.20 Å
R-free 0.292
|
|
3K0J
Crystal structure of the E. coli ThiM riboswitch in complex with thiamine pyrophosphate and the U1A crystallization module
Deposited 2009-09-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
2–97(96 aa)
Fragment:UNP residues 2-97, RRM 1 domain
Chain C
2–97(96 aa)
Fragment:UNP residues 2-97, RRM 1 domain
|
Mutation:Y231H,Q236R
Mutation:Y231H,Q236R
|
TPP THIAMINE DIPHOSPHATE × 1
MG MAGNESIUM ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;298 K;20% (v/v) PEG 550 MME, 20% MPD, and 80 mM sodium citrate (pH 5.6), VAPOR DIFFUSION, temperature 298K
|
Resolution 3.10 Å
R-free 0.279
|
|
3K0J
Crystal structure of the E. coli ThiM riboswitch in complex with thiamine pyrophosphate and the U1A crystallization module
Deposited 2009-09-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain B
2–97(96 aa)
Fragment:UNP residues 2-97, RRM 1 domain
Chain D
2–97(96 aa)
Fragment:UNP residues 2-97, RRM 1 domain
|
Mutation:Y231H,Q236R
Mutation:Y231H,Q236R
|
TPP THIAMINE DIPHOSPHATE × 1
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;298 K;20% (v/v) PEG 550 MME, 20% MPD, and 80 mM sodium citrate (pH 5.6), VAPOR DIFFUSION, temperature 298K
|
Resolution 3.10 Å
R-free 0.279
|
|
3L3C
Crystal structure of the Bacillus anthracis glmS ribozyme bound to Glc6P
Deposited 2009-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
7–96(90 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 4
G6P 6-O-phosphono-alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.85 Å
R-free 0.303
|
|
3L3C
Crystal structure of the Bacillus anthracis glmS ribozyme bound to Glc6P
Deposited 2009-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
7–96(90 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 4
G6P 6-O-phosphono-alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.85 Å
R-free 0.303
|
|
3L3C
Crystal structure of the Bacillus anthracis glmS ribozyme bound to Glc6P
Deposited 2009-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
7–96(90 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 4
G6P 6-O-phosphono-alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.85 Å
R-free 0.303
|
|
3L3C
Crystal structure of the Bacillus anthracis glmS ribozyme bound to Glc6P
Deposited 2009-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
7–96(90 aa)
Fragment:RNA BINDING DOMAIN
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 4
G6P 6-O-phosphono-alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
vapor diffusion, sitting drops;pH 6.8;298 K;11% PEG 8000, 9% DMSO, 0.02M SODIUM CACODYLATE, 0.02M MAGNESIUM CHLORIDE, 0.15M POTASSIUM CHLORIDE, pH 6.8, vapor diffusion, sitting drops, temperature 298K
|
Resolution 2.85 Å
R-free 0.303
|
|
3MUM
Crystal Structure of the G20A mutant c-di-GMP riboswith bound to c-di-GMP
Deposited 2010-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;22% PEG 550 MME, 5 mM MgSO4, 50 mM MES, pH 6.0, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.90 Å
R-free 0.265
|
|
3MUR
Crystal Structure of the C92U mutant c-di-GMP riboswith bound to c-di-GMP
Deposited 2010-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;25% PEG 550 MME, 5 mM MgSO4, 50 mM MES, pH 6.0, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.252
|
|
3MUT
Crystal Structure of the G20A/C92U mutant c-di-GMP riboswith bound to c-di-GMP
Deposited 2010-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
|
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;25% PEG 550 MME, 5 mM MgSO4, 50 mM MES, pH 6.0, 300 mM NaCl. Streak seeding after 3-6 hours, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.268
|
|
3MUV
Crystal Structure of the G20A/C92U mutant c-di-GMP riboswith bound to c-di-AMP
Deposited 2010-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
|
2BA (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8 ]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;298 K;25% PEG 550 MME, 5 mM MgSO4, 50 mM MES, pH 6.0, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.20 Å
R-free 0.260
|
|
3MXH
Native structure of a c-di-GMP riboswitch from V. cholerae
Deposited 2010-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
1–98(98 aa)
Fragment:UNP residues 1-98
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 5
C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;22% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.239
|
|
3P49
Crystal Structure of a Glycine Riboswitch from Fusobacterium nucleatum
Deposited 2010-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
1–98(98 aa)
Fragment:RNA BINDING DOMAIN (UNP RESIDUES 1-98)
|
Mutation:Y31H Q36R
|
MG MAGNESIUM ION × 13
GLY GLYCINE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;25% PEGmme550, 0.05M HEPES PH 7.0, 0.01M MgCL2, 0.025M NaOAC pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.55 Å
R-free 0.310
|
|
3PGW
Crystal structure of human U1 snRNP
Deposited 2010-11-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 9
PDB declaration: undecameric
|
Chain A
1–282(282 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;277 K;8-10% PEG 4000, 0.1 M Trisodium citrate, 2 mM EDTA, 100 mM NaCl, 1-2% Anapoe X-305, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 4.40 Å
R-free 0.348
|
|
3PGW
Crystal structure of human U1 snRNP
Deposited 2010-11-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 9
PDB declaration: undecameric
|
Chain P
1–282(282 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;277 K;8-10% PEG 4000, 0.1 M Trisodium citrate, 2 mM EDTA, 100 mM NaCl, 1-2% Anapoe X-305, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 4.40 Å
R-free 0.348
|
|
3R1H
Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound
Deposited 2011-03-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA binding domain (UNP residues 1-98)
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 14
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;295 K;50 mM sodium cacodylate, pH 6.0, 20 mM calcium acetate, 10 mM strontium acetate, 1mM spermine, 16-20% MPD, crystals in same conditions with 30% MPD were crushed and used as microseeding stocks, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.15 Å
R-free 0.255
|
|
3R1H
Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound
Deposited 2011-03-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA binding domain (UNP residues 1-98)
|
Mutation:Y31H,Q36R
|
CA CALCIUM ION × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;295 K;50 mM sodium cacodylate, pH 6.0, 20 mM calcium acetate, 10 mM strontium acetate, 1mM spermine, 16-20% MPD, crystals in same conditions with 30% MPD were crushed and used as microseeding stocks, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.15 Å
R-free 0.255
|
|
3R1L
Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Mg2+ bound
Deposited 2011-03-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–98(98 aa)
Fragment:RNA binding domain (UNP residues 1-98)
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 25
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;295 K;50 mM sodium cacodylate, pH 6.0, 20 mM calcium chloride, 10 mM strontium chloride, 1 mM spermine, 26% MPD, crystals were crushed and used as microseeding stocks, calcium chloride was replaced with magnesium chloride prior to freezing, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.12 Å
R-free 0.240
|
|
3R1L
Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Mg2+ bound
Deposited 2011-03-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain D
1–98(98 aa)
Fragment:RNA binding domain (UNP residues 1-98)
|
Mutation:Y31H,Q36R
|
MG MAGNESIUM ION × 21
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;295 K;50 mM sodium cacodylate, pH 6.0, 20 mM calcium chloride, 10 mM strontium chloride, 1 mM spermine, 26% MPD, crystals were crushed and used as microseeding stocks, calcium chloride was replaced with magnesium chloride prior to freezing, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.12 Å
R-free 0.240
|
|
3UCU
The c-di-GMP-I riboswitch bound to pGpG
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain P
1–98(98 aa)
Fragment:RNA binding domain, UNP residues 1-98
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.80 Å
R-free 0.262
|
|
3UCZ
The c-di-GMP-I riboswitch bound to GpG
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain P
1–98(98 aa)
Fragment:RNA binding domain, UNP residues 1-98
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.80 Å
R-free 0.269
|
|
3UD3
The C92U mutant c-di-GMP-I riboswitch bound to pGpA
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain P
1–98(98 aa)
Fragment:RNA binding domain, UNP residues 1-98
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;26% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.10 Å
R-free 0.258
|
|
3UD4
The C92U mutant c-di-GMP-I riboswitch bound to GpA
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain P
1–98(98 aa)
Fragment:RNA binding domain, UNP residues 1-98
|
Mutation:Y31H, Q36R
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å
R-free 0.290
|
|
4C4W
Structure of a rare, non-standard sequence k-turn bound by L7Ae protein
Deposited 2013-09-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 3
PDB declaration: tetrameric
|
Chain A
1–102(102 aa)
Fragment:RRM 1 DOMAIN, RESIDUES 1-102
Chain B
1–102(102 aa)
Fragment:RRM 1 DOMAIN, RESIDUES 1-102
|
Not recorded
|
2HP DIHYDROGENPHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;100 MM TRISHCL 8.5 AND 2.0 M MONO-AMMONIUM DIHYDROGEN PHOSPHATE
|
Resolution 2.95 Å
R-free 0.211
|
|
4C4W
Structure of a rare, non-standard sequence k-turn bound by L7Ae protein
Deposited 2013-09-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Heteromer;Protein × 3
PDB declaration: tetrameric
|
Chain E
1–102(102 aa)
Fragment:RRM 1 DOMAIN, RESIDUES 1-102
Chain F
1–102(102 aa)
Fragment:RRM 1 DOMAIN, RESIDUES 1-102
|
Not recorded
|
2HP DIHYDROGENPHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;100 MM TRISHCL 8.5 AND 2.0 M MONO-AMMONIUM DIHYDROGEN PHOSPHATE
|
Resolution 2.95 Å
R-free 0.211
|
|
4PR6
A Second Look at the HDV Ribozyme Structure and Dynamics.
Deposited 2014-03-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
4–96(93 aa)
Fragment:RNA BINDING DOMAIN, UNP residues 101-244
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 16
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;PEG MME 2000, LITHIUM SULPHATE, SPERMINE, TRIS, COBALT HEXAMMINE, MAGNESIUM
CHLORIDE, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.241
|
|
4PRF
A Second Look at the HDV Ribozyme Structure and Dynamics.
Deposited 2014-03-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
1–100(100 aa)
Fragment:U1A_RBD, UNP residues 98-173
|
Mutation:Y31H, Q36R
|
SR STRONTIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;SrCl2, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å
R-free 0.252
|
|
4W90
Crystal structure of Bacillus subtilis cyclic-di-AMP riboswitch ydaO
Deposited 2014-08-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
6–96(91 aa)
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
2BA (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8 ]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide × 2
MG MAGNESIUM ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.2;293 K;PEG 3350
|
Resolution 3.12 Å
R-free 0.288
|
|
4W92
Crystal structure of Bacillus subtilis cyclic-di-AMP riboswitch ydaO
Deposited 2014-08-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
6–96(91 aa)
Fragment:unp residues 6-96
|
Mutation:Y31H, Q36R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 5
K POTASSIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
2BA (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8 ]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.2;293 K;PEG 3350
|
Resolution 3.21 Å
R-free 0.289
|
|
4YB1
20A Mutant c-di-GMP Vc2 Riboswitch bound with 3',3'-cGAMP
Deposited 2015-02-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain P
7–97(91 aa)
Fragment:UNP residues 7-97
|
Not recorded
|
MG MAGNESIUM ION × 1
4BW 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M Na-citrate pH 5.5, 5% PEG1000, 35% iso-propanol
|
Resolution 2.08 Å
R-free 0.298
|
|
5DDO
Structural and Dynamic Basis for Low Affinity-High Selectivity Binding of L-glutamine by the Gln-riboswitch
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain G
2–98(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M Na-formate, 21% (w/v) PEG3350
|
Resolution 3.10 Å
R-free 0.289
|
|
5DDO
Structural and Dynamic Basis for Low Affinity-High Selectivity Binding of L-glutamine by the Gln-riboswitch
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
2–98(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M Na-formate, 21% (w/v) PEG3350
|
Resolution 3.10 Å
R-free 0.289
|
|
5DDP
L-glutamine riboswitch bound with L-glutamine
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain D
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
MG MAGNESIUM ION × 5
NA SODIUM ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol
|
Resolution 2.30 Å
R-free 0.243
|
|
5DDP
L-glutamine riboswitch bound with L-glutamine
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
MG MAGNESIUM ION × 4
NA SODIUM ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol
|
Resolution 2.30 Å
R-free 0.243
|
|
5DDQ
L-glutamine riboswitch bound with L-glutamine soaked with Mn2+
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain D
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
MN MANGANESE (II) ION × 3
MG MAGNESIUM ION × 1
NA SODIUM ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol, 2 mM MnCl2
|
Resolution 2.40 Å
R-free 0.257
|
|
5DDQ
L-glutamine riboswitch bound with L-glutamine soaked with Mn2+
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
MN MANGANESE (II) ION × 2
MG MAGNESIUM ION × 2
NA SODIUM ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol, 2 mM MnCl2
|
Resolution 2.40 Å
R-free 0.257
|
|
5DDR
L-glutamine riboswitch bound with L-glutamine soaked with Cs+
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain D
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
K POTASSIUM ION × 4
MG MAGNESIUM ION × 6
CS CESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol, 20 mM CsCl
|
Resolution 2.60 Å
R-free 0.271
|
|
5DDR
L-glutamine riboswitch bound with L-glutamine soaked with Cs+
Deposited 2015-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
2–98(97 aa)
|
Not recorded
|
GLN GLUTAMINE × 1
K POTASSIUM ION × 3
MG MAGNESIUM ION × 5
CS CESIUM ION × 4
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;.1 M HEPES-sodium, pH 7.0, 40% (v/v) 2-methyl-2,4-pentanediol, 20 mM CsCl
|
Resolution 2.60 Å
R-free 0.271
|
|
5FJ4
Structure of the standard kink turn HmKt-7 as stem loop bound with U1A and L7Ae proteins
Deposited 2015-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 3
PDB declaration: tetrameric
|
Chain A
1–102(102 aa)
Fragment:RRM 1 DOMAIN, UNP RESIDUES 1-102
Chain B
1–102(102 aa)
Fragment:RRM 1 DOMAIN, UNP RESIDUES 1-102
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;0.1 M TRIS HYDROCHLORIDE PH 8.5, 2.0 M MONO-AMMONIUM DIHYDROGEN PHOSPHATE
|
Resolution 2.95 Å
R-free 0.237
|
|
5FJ4
Structure of the standard kink turn HmKt-7 as stem loop bound with U1A and L7Ae proteins
Deposited 2015-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Heteromer;Protein × 3
PDB declaration: tetrameric
|
Chain E
1–102(102 aa)
Fragment:RRM 1 DOMAIN, UNP RESIDUES 1-102
Chain F
1–102(102 aa)
Fragment:RRM 1 DOMAIN, UNP RESIDUES 1-102
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;0.1 M TRIS HYDROCHLORIDE PH 8.5, 2.0 M MONO-AMMONIUM DIHYDROGEN PHOSPHATE
|
Resolution 2.95 Å
R-free 0.237
|
|
6LAS
the wildtype SAM-VI riboswitch bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain E
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.71 Å
R-free 0.244
|
|
6LAS
the wildtype SAM-VI riboswitch bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.71 Å
R-free 0.244
|
|
6LAS
the wildtype SAM-VI riboswitch bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.71 Å
R-free 0.244
|
|
6LAU
the wildtype SAM-VI riboswitch bound to SAH
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain E
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
CS CESIUM ION × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 3.11 Å
R-free 0.252
|
|
6LAU
the wildtype SAM-VI riboswitch bound to SAH
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 3.11 Å
R-free 0.252
|
|
6LAU
the wildtype SAM-VI riboswitch bound to SAH
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 3.11 Å
R-free 0.252
|
|
6LAX
the mutant SAM-VI riboswitch (U6C) bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain E
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;sodium acetate trihydrate, polyethylene glycol 4,000
|
Resolution 2.70 Å
R-free 0.239
|
|
6LAX
the mutant SAM-VI riboswitch (U6C) bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;sodium acetate trihydrate, polyethylene glycol 4,000
|
Resolution 2.70 Å
R-free 0.239
|
|
6LAX
the mutant SAM-VI riboswitch (U6C) bound to SAM
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;sodium acetate trihydrate, polyethylene glycol 4,000
|
Resolution 2.70 Å
R-free 0.239
|
|
6LAZ
the wildtype SAM-VI riboswitch bound to a N-mustard SAM analog M1
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain E
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
|
MG MAGNESIUM ION × 1
E7X (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-hydroxyethyl)amino]-2-azaniumyl-butanoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.76 Å
R-free 0.223
|
|
6LAZ
the wildtype SAM-VI riboswitch bound to a N-mustard SAM analog M1
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
|
E7X (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-hydroxyethyl)amino]-2-azaniumyl-butanoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.76 Å
R-free 0.223
|
|
6LAZ
the wildtype SAM-VI riboswitch bound to a N-mustard SAM analog M1
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
6–96(91 aa)
|
Mutation:Y31H, Q36R, S46K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M sodium acetate trihydrate pH 4.6, 10% w/v polyethylene glycol 4,000
|
Resolution 2.76 Å
R-free 0.223
|
|
6QX9
Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).
Deposited 2019-03-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 65
PDB declaration: 71-meric
|
Chain 1A
1–282(282 aa)
|
Not recorded
|
ZN ZINC ION × 6
MG MAGNESIUM ION × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
IHP INOSITOL HEXAKISPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.28 Å
|
|
6SQN
Structure of the U1A variant A1-98 Y31H/Q36R/F56W triple mutant co-crystallized with RNA
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 3
PDB declaration: hexameric
|
Chain A
2–98(97 aa)
Chain B
2–98(97 aa)
Chain C
2–98(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.2 M ammonium sulfate, 0.1 M tri-potassium citrate
|
Resolution 2.05 Å
R-free 0.249
|
|
6SQQ
Structure of the U1A variant A1-98 Y31H/Q36R/F56W triple mutant in complex with RNA obtained by soaking
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 3
PDB declaration: hexameric
|
Chain AAA
1–98(98 aa)
Chain BBB
1–98(98 aa)
Chain CCC
1–98(98 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 2.37 Å
R-free 0.294
|
|
6SQT
Structure of the U1A variant A1-98 Y31H/Q36R/F56W triple mutant
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain AAA
1–98(98 aa)
Chain BBB
1–98(98 aa)
Chain CCC
1–98(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 1.84 Å
R-free 0.245
|
|
6SQV
Structure of the U1A variant A1-98 Y31H/Q36R/R70W
Deposited 2019-09-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain AAA
1–97(97 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 2.45 Å
R-free 0.273
|
|
6SQV
Structure of the U1A variant A1-98 Y31H/Q36R/R70W
Deposited 2019-09-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain BBB
1–97(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 2.45 Å
R-free 0.273
|
|
6SQV
Structure of the U1A variant A1-98 Y31H/Q36R/R70W
Deposited 2019-09-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain CCC
1–97(97 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 2.45 Å
R-free 0.273
|
|
6SQV
Structure of the U1A variant A1-98 Y31H/Q36R/R70W
Deposited 2019-09-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain DDD
1–97(97 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 2.45 Å
R-free 0.273
|
|
6SR7
Structure of the U1A variant A1-98 Y31H/Q36R/K98W
Deposited 2019-09-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain AAA
1–98(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 1.86 Å
R-free 0.256
|
|
6SR7
Structure of the U1A variant A1-98 Y31H/Q36R/K98W
Deposited 2019-09-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain BBB
1–98(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 1.86 Å
R-free 0.256
|
|
6SR7
Structure of the U1A variant A1-98 Y31H/Q36R/K98W
Deposited 2019-09-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain CCC
1–98(98 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 1.86 Å
R-free 0.256
|
|
6SR7
Structure of the U1A variant A1-98 Y31H/Q36R/K98W
Deposited 2019-09-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain DDD
1–98(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2.2 M ammonium sulfate, 0.2 M tri-potassium citrate
|
Resolution 1.86 Å
R-free 0.256
|
|
7AEP
Solution structure of U1-A RRM2 (190-282)
Deposited 2020-09-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
157–282(126 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;313 K;Ionic strength (raw mmCIF value) 60;Pressure atmospheric
NMR sample composition
10 mM NaPO4, 50 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
7D7V
Crystal Structure of the Domain1 of NAD+ Riboswitch with nicotinamide adenine dinucleotide (NAD+) and U1A protein
Deposited 2020-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain C
5–96(92 aa)
|
Mutation:Y27H, Q32R
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 8
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Mg(OAc)2, 0.1 M C2H6AsNaO2, pH 6.5, 30% MPD
|
Resolution 2.80 Å
R-free 0.308
|
|
7DLZ
Crystal Structure of Methyltransferase Ribozyme
Deposited 2020-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 4
PDB declaration: hexameric
|
Chain A
1–102(102 aa)
Chain B
1–102(102 aa)
Chain C
1–102(102 aa)
Chain D
1–102(102 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291 K;polyethylene glycol 3350
|
Resolution 3.00 Å
R-free 0.266
|
|
7DWH
Complex structure of SAM-dependent methyltransferase ribozyme
Deposited 2021-01-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 4
PDB declaration: hexameric
|
Chain A
1–102(102 aa)
Chain B
1–102(102 aa)
Chain C
1–102(102 aa)
Chain D
1–102(102 aa)
|
Not recorded
|
CU COPPER (II) ION × 2
SAM S-ADENOSYLMETHIONINE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.7;291 K;sodium phosphate monobasic monohydrate, polyethylene glycol 3350
|
Resolution 3.10 Å
R-free 0.258
|
|
7LHX
Human U1A protein with F37M and F77M mutations for improved phasing
Deposited 2021-01-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–98(98 aa)
|
Mutation:Y31H, Q36R, F37M, F77M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 1
ACT ACETATE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;2.7-3.1 M Sodium Acetate
|
Resolution 2.20 Å
R-free 0.213
|
|
7VPX
The cryo-EM structure of the human pre-A complex
Deposited 2021-10-18
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 31
PDB declaration: 35-meric
|
Chain M
1–282(282 aa)
|
Not recorded
|
ZN ZINC ION × 6
SJT spliceostatin A (form II) × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8GXB
Crystal structure of NAD+ -II riboswitch in complex with NAD+
Deposited 2022-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 5
PDB declaration: heptameric
|
Chain C
2–98(97 aa)
Chain D
2–98(97 aa)
Chain E
2–98(97 aa)
Chain F
2–98(97 aa)
Chain G
2–98(97 aa)
|
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
|
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 2
MG MAGNESIUM ION × 19
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2M KCl, 0.01M MgCl2, 0.05M MES pH 5.6, 5% PEG8000
|
Resolution 2.15 Å
R-free 0.269
|
|
8GXC
Crystal structure of NAD+ -II riboswitch in complex with NMN
Deposited 2022-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 5
PDB declaration: heptameric
|
Chain C
2–98(97 aa)
Chain D
2–98(97 aa)
Chain E
2–98(97 aa)
Chain F
2–98(97 aa)
Chain G
2–98(97 aa)
|
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
Mutation:Y31H, Q36R
|
NMN BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE × 2
MG MAGNESIUM ION × 16
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2M KCl, 0.01M MgCl2, 0.05M MES pH 5.6, 5% PEG8000
|
Resolution 2.50 Å
R-free 0.269
|
|
9QEQ
Structure of the transcribing Pol II-DSIF-SPT6-U1 snRNP complex
Deposited 2025-03-10
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 24
PDB declaration: 28-meric
|
Chain c
1–282(282 aa)
|
Not recorded
|
ZN ZINC ION × 8
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;20 mM Hepes, 100 mM NaCl, 3 mM MgCl2, 0.5 mM TCEP
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
9YXV
Cryo-EM structure of the core region of cIL-U1A-Fab1R-PGA1-sfFab quaternary complex at 2.9 A resolution
Deposited 2025-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 6
PDB declaration: heptameric
|
Chain A
2–98(97 aa)
|
Mutation:Y31H, Q36R
|
DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;10 mM HEPES, 75 mM NaCl, 5 mM MgCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|